Companies
Foundation Medicine
This profile is still being built. It is not yet listed in the company index.
MedTwenty Indices and trackers are editorial indicators and business information. They are not investment, financial, legal or medical advice, and not a regulated benchmark.
Summary
Comprehensive genomic profiling provider owned by Roche, and the principal competitor for NHS pathology network contracts.
Finances
Not published (small company accounts)
Timeline
No verified timeline entries yet.